Orbito-nasal Fistula, A Therapeutic Challenge Against an Uncommon Manifestation in Granulomatosis with Polyangiitis
Aixa Lucia Mercé*, María Lourdes Mamani Ortega, Vanesa Marisel Bejarano and Anastasia Secco
Section of Rheumatology, Hospital B. Rivadavia, Buenos Aires
*Corresponding Author: Aixa Lucia Mercé, Section of Rheumatology, Hospital B. Rivadavia, Buenos Aires.
Received:
January 09, 2023; Published: April 04, 2023
Abstract
Granulomatosis with Polyangiitis (GPA) is a clinical-pathological condition that presents with granulomatous inflammation of the upper and lower respiratory tract, focal necrotizing glomerulonephritis and necrotizing vasculitis of small and medium-sized vessels (capillaries, venules, arterioles and arteries). Orbital GPA involvement ranging from 7-45%. The lacrimal gland can occasionally be affected in isolation and be the initial manifestation of the disease. We present the case of a patient with GPA and nasolacrimal fistula.
Keywords: Granulomatosis Con Polyangiitis; Orbito-Nasal Fistula; Corneal Erosion; Nasal Septum Perforation
References
- Rheumatic Diseases, Update Valencian Society Rheumatology. Chapter 17: Anca Vasculitis, Granulomatosis with Polyangiitis (2013): 395-413.
- Kitching AR., et al. “Vasculitis asociada a ANCA”. Nature Reviews Disease Primers 6 (2020): 71.
- Cao Y., et al. “The DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans”. Journal of the American Society of Nephrology 22 (2011): 1161.
- Mahr A., et al. “Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate”. Rheumatoid Arthritis 51 (2010): 92.
- Bossuyt X., et al. “Position paper: 2017 revised international consensus on ANCA testing in granulomatosis with polyangiitis and microscopic polyangiitis”. Nature Reviews Rheumatology 13 (2017): 683.
- Finkielman JD., et al. “ANCAs are detectable in almost all patients with severe active Wegener's granulomatosis”. American Journal of Medicine 120 (2007): 643.e9.
- Carmelo Morales-Angulo., et al. “Otorhinolaryngological manifestations in patients with Wegener's granulomatosis (granulomatosis with polyangiitis)”. Acta Otolaryngológica Española3 (2012): 206-211.
- Fuchs HA and Tanner SB. “Granulomatous disorders of the nose and paranasal sinuses”. Current Opinion in Otolaryngology and Head and Neck Surgery 1 (2009): 23-27.
- Sollima S., et al. “Visceral leishma-niasis in a patient with Wegener’s granulomatosis”. Rheumatology (Oxford) 7 (2004): 935-937.
- Holle J., et al. “Orbital masses in granulomatosis with polyangiitis are associated with refractory course and high burden of local damage”. Rheumatology 52 (2013): 875-882.
- Tan LT., et al. “Clinical and imaging features of lacrimal gland involvement in granulomatosis with polyangiitis”. Ophthalmology 122 (2015): 2125-2129.
- Isa H., et al. “Histopathological features predictive of a clinical diagnosis of ophthalmic granulomatosis with polyangiitis (GPA)”. International Journal of Clinical and Experimental Pathology 5 (2012): 684-689.
- Chung SA., et al. “American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis”. Arthritis Care Research (Hoboken) 73.8 (2021): 1088-1105.
- Keogh KA., et al. “Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis”. Arthritis Rheum 52 (2005): 262-268.
- Keogh KA., et al. “Rituximab for refractory Wegener's Granulomatosis. Report of prospective, open-label pilot trial”. American Journal of Respiratory and Critical Care Medicine 173 (2006): 180-187.
- Ronda JM., et al. “Midfacial necrosis secondary to cocaine-abuse”. Acta Otorrinolaringológica Española 2 (2002): 129-132.
- Parker NP., et al. “The dilemma of midline destructive lesions: a case series and diagnostic review”. American Journal of Otolaryngology 2 (2010): 104.
Citation
Copyright